MENU

Angela Jain, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Education, Training & Credentials

Educational Background

  • Fellow, Hematology and Oncology, Temple University Hospital/ Fox Chase Cancer Center, Philadelphia, PA, 2013
  • Resident, Internal Medicine, Temple University Hospital, Philadelphia, PA, 2010 
  • MD, Temple University School of Medicine, Philadelphia, PA, 2007 
Patient Stories

Frances Johnson

Ovarian & Primary Peritoneal Cancer

Frances Johnson

Ovarian & Primary Peritoneal Cancer

At age 81, in the fall of 2013, Frances Johnson said she began to notice pain near the left side of her waist.  She had a yearly physical scheduled with her primary doctor, so she raised her concerns then. “I told my primary doctor that I had the pain and he sent me for a CAT scan. After the results, I was told everything looked fine. I began to accept the pain as normal pain from getting older,” shares Fran.

Melanie Mizenko

Endometrial (Uterine) Cancer

Melanie Mizenko

Endometrial (Uterine) Cancer

Testing revealed a suspicious mass in her uterus, but most of the doctors suggested it was a fibroid tumor. Melanie's local doctor explained she had stage IV endometrial cancer. That day Melanie joined the "club" of thousands of people diagnosed with cancer each year.

Michelle Sealer

Ovarian & Primary Peritoneal Cancer

Michelle Sealer

Ovarian & Primary Peritoneal Cancer

For over 25 years, Michelle Sealer, who is now in her forties, has valiantly fought ovarian cancer while keeping her faith. "I am a religious person and I pray a lot. I believe my faith has helped guide me through the years," says Michelle.

Michelle’s medical journey started when she was in college in 1993. "I started having irregular periods, pain in my right side, and I just wasn't feeling right. I visited the college health center and then was told to go to the local community hospital for treatment," she remembers.

Publications

Selected Publications

Jain, A et al. “Metastatic Mucinous Ovarian Cancer and Treatment Decisions Based on Histology and Molecular Markers rather than the Primary Location” JNCCN September 2012. PubMed